查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1957666

2026年全球血漿療法市場報告

Plasma Therapy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，血漿療法市場發展迅速。預計該市場規模將從2025年的6.1億美元成長到2026年的6.9億美元，複合年成長率達12.6%。過去幾年成長要素包括：人們對血漿療法療效的認知度較低、對傳統療法的依賴、整形外科和運動醫學領域手術數量的增加、醫院和診所基礎設施的擴建，以及富血小板血漿（PRP）在美容手術中的早期應用。

預計未來幾年，血漿療法市場將快速成長，到2030年將達到11.3億美元，複合年成長率（CAGR）為13.0%。預測期內的成長要素包括：先進的富血小板血漿（PRP）和富血小板纖維蛋白（PRF）製劑的研發、再生醫學研究的進展、血漿療法在慢性疾病和心臟損傷治療中的應用不斷擴大、皮膚科和牙科的廣泛應用，以及臨床試驗和研究機構數量的增加。預測期內的主要趨勢包括：富血小板血漿（PRP）和富血小板纖維蛋白（PRF）療法的應用日益普及、在再生醫學和整形外科的應用不斷擴大、在皮膚科、毛髮再生和整形外科領域的應用日益廣泛、對注射型和膜基纖維蛋白產品的需求不斷成長，以及研究和臨床試驗的整合以提高治療效果。

預計骨關節炎盛行率的不斷上升將推動預測期內血漿療法市場的成長。富血小板血漿（PRP）是一種血漿療法，被廣泛認為是治療骨關節炎安全有效的選擇。 PRP是一種富含生長因子的濃縮自體血液製品，透過注射到受累關節中，減輕發炎並抑制疾病進展，從而緩解症狀。例如，根據荷蘭出版商愛思唯爾（Elsevier）出版的日誌，截至2023年9月，預計到2050年，全球骨關節炎病例數將顯著增加。具體而言，膝骨關節炎病例預計將增加74.9%（範圍為59.4%至89.9%），手腕關節關節炎病例預計將增加48.6%（範圍為35.9%至67.1%）和78.6%（範圍為57.7%至105.3%），其他類型將增加1%1%（3%1%）。骨關節炎的常用治療方法包括自體軟骨細胞移植術和支架植入。在此背景下，骨關節炎盛行率的不斷上升預計將推動對血漿療法的需求成長。

主要企業正在推出創新產品，例如ESG-410，以滿足不斷變化的臨床需求並拓展治療選擇。 ESG-410是一款電外科發生器，旨在提高非肌肉層浸潤性膀胱癌（NMIBC）和良性前列腺增生（BPH）的治療效率和療效。例如，2023年6月，日本醫療技術公司Olympus Corporation宣布推出ESG-410，這是一款用於治療膀胱癌和BPH的新一代電外科發生器。 ESG-410採用了先進的設計，例如改進的電容器，可增強點火過程中的等離子體穩定性。它實現了快速點火和最佳化的等離子體穩定性，與ESG-400相比，性能顯著提升，尤其是在使用不同尺寸的切除環和橢圓形按鈕時。 ESG-410電外科產生器可透過多種切除環、電極和汽化裝置選項，支援NMIBC和BPH的先進治療。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球血漿療法市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 血小板濃縮血漿（PRP）和血小板濃縮纖維蛋白（PRF）療法已廣泛應用。
    • 拓展其在再生醫學和整形外科。
    • 在皮膚科、毛髮再生和整形外科領域的應用日益廣泛。
    • 對注射型和膜基纖維蛋白產品的需求不斷成長
    • 整合研究和臨床試驗以提高治療效果

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 研究所
  • 研究所
  • 皮膚科診所
  • 整形外科和運動醫學中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球血漿療法市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球血漿療法市場規模、對比及成長率分析
  • 全球血漿療法市場表現：規模與成長，2020-2025年
  • 全球血漿療法市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按類型
  • 純 PRP、富含白血球的 PRP、純血小板富集纖維蛋白 (PRF)、富含白血球的纖維蛋白 (L-PRF)
  • 透過使用
  • 整形外科、關節炎、慢性肌腱炎、骨骼修復和再生、皮膚科、男性型脫髮症、整形外科、牙科、心肌損傷等用途。
  • 最終用戶
  • 醫院、診所、研究所、研究機構
  • 按類型細分：純 PRP
  • 高濃度 PRP，低濃度 PRP
  • 按類型細分：富含白血球的PRP
  • 含白血球的富血小板血漿，含生長因子的富血小板血漿
  • 按類型細分：純血小板濃縮纖維蛋白（PRF）
  • 注射型富血小板纖維蛋白（PRF）、膜狀富血小板纖維蛋白（PRF）
  • 按類型細分：富含白血球的纖維蛋白（L-PRF）
  • L-PRF凝塊、L-PRF膜

第10章 區域與國別分析

  • 全球血漿療法市場：按地區分類，實際結果和預測，2020-2025年、2025-2030年、2035年
  • 全球血漿療法市場：按國家/地區分類，實際結果和預測，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 血漿療法市場：競爭格局及市場佔有率（2024年）
  • 血漿療法市場：公司估值矩陣
  • 血漿療法市場：公司概況
    • Takeda Pharmaceutical Company Limited
    • Bio Products Laboratory Ltd.
    • Arthrex Inc.
    • Biotest AG
    • China Biologic Products Holdings Inc.

第37章 其他大型企業和創新企業

  • DePuy Synthes Companies, CSL Limited, Grifols SA, Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年血漿療法市場：提供新機會的國家
  • 2030年血漿療法市場：充滿新機會的細分市場
  • 2030年血漿療法市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH6MPTHE07_G26Q1

Plasma therapy is a treatment approach that replaces missing or insufficient proteins to support individuals in leading healthier and more productive lives. It delivers antibodies to patients undergoing therapy through blood plasma donated by individuals who have recovered from illness.

The main types of plasma therapy include pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). Pure Platelet-Rich Plasma (P-PRP), also known as leucocyte-poor PRP products, are activated formulations that do not contain leucocytes and feature a low-density fibrin network. The various applications encompass orthopedics, arthritis, chronic tendinitis, bone repair and regeneration, dermatology, androgenic alopecia, plastic surgery, dental procedures, cardiac muscle injury, and others, and are utilized across multiple settings such as hospitals and clinics, laboratories, and research institutes.

Tariffs have influenced the plasma therapy market by increasing costs of imported PRP/PRF kits, reagents, and medical devices used in therapy preparation. Segments like leukocyte-rich PRP and injectable PRF are most affected, with regions such as North America and Europe facing higher import duties. This has raised treatment costs and slowed adoption in hospital and clinic settings. On the positive side, tariffs have encouraged local manufacturing, innovation in plasma therapy delivery systems, and development of cost-effective alternatives.

The plasma therapy market research report is one of a series of new reports from The Business Research Company that provides plasma therapy market statistics, including plasma therapy industry global market size, regional shares, competitors with a plasma therapy market share, detailed plasma therapy market segments, market trends and opportunities, and any further data you may need to thrive in the plasma therapy industry. This plasma therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plasma therapy market size has grown rapidly in recent years. It will grow from $0.61 billion in 2025 to $0.69 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to limited awareness about plasma therapy benefits, reliance on conventional treatments, growing orthopedic and sports medicine procedures, increasing hospital and clinic infrastructure, early adoption of prp in cosmetic procedures.

The plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $1.13 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to development of advanced prp and prf formulations, rising regenerative medicine research, expansion of plasma therapy applications in chronic and cardiac injuries, increasing adoption in dermatology and dental care, growth of clinical trials and research institutes. Major trends in the forecast period include growing adoption of platelet-rich plasma (prp) and platelet-rich fibrin (prf) therapies, expansion of regenerative medicine and orthopedic applications, increasing use in dermatology, hair restoration, and plastic surgery, rising demand for injectable and membrane-based fibrin products, integration of research and clinical trials for enhanced therapeutic outcomes.

The increasing incidence of osteoarthritis is expected to fuel the growth of the plasma therapy market during the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is widely regarded as a safe and effective treatment option for osteoarthritis. PRP is a concentrated autologous blood product rich in growth factors that is injected into affected joints to relieve symptoms by reducing inflammation and slowing the progression of the disease. For example, in September 2023, according to the Journal of Elsevier, a Netherlands-based publishing company, global osteoarthritis cases are projected to rise significantly by 2050, with increases of 74.9% (ranging from 59.4% to 89.9%) for knee osteoarthritis, 48.6% (ranging from 35.9% to 67.1%) for hand osteoarthritis, 78.6% (ranging from 57.7% to 105.3%) for hip osteoarthritis, and 95.1% (ranging from 68.1% to 135.0%) for other types of osteoarthritis. Common treatment approaches for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Consequently, the growing prevalence of osteoarthritis is anticipated to drive demand for plasma therapy.

Key companies operating in the plasma therapy market are launching innovative products, such as ESG-410, to address evolving clinical needs and expand available treatment options. ESG-410 is an electrosurgical generator designed to improve efficiency and performance in the treatment of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a Japan-based medical technology company, introduced the next-generation ESG-410 electrosurgical generator for the treatment of bladder cancer and enlarged prostate conditions. The ESG-410 incorporates advanced design features, including enhanced capacitors that ensure improved plasma stability during ignition. It offers rapid ignition and optimized plasma stability, delivering performance enhancements compared to the ESG-400, particularly when used with different loop sizes and oval buttons. The ESG-410 electrosurgical generator supports advanced treatment for NMIBC and BPH through a wide selection of resection loops, electrodes, and vaporization instruments.

In October 2025, Accord Plasma B.V., a Netherlands-based provider of plasma-derived therapies, acquired Prothya Biosolutions B.V. for an undisclosed amount. Through this acquisition, Accord Plasma B.V. aims to strengthen its global plasma therapy operations, improve production efficiency, expand access to high-quality plasma-derived products, and reinforce its position within the biopharmaceutical industry. Prothya Biosolutions B.V. is a US-based plasma collection and manufacturing company specializing in plasma-derived therapies.

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plasma therapy market includes revenues earned by entities by replacing missing or deficient proteins and developing better means of managing the disease. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasma Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses plasma therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plasma therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Pure PRP; Leukocyte-rich PRP; Pure Platelet-rich Fibrin (PRF); Leukocyte-rich Fibrin (L-PRF)
  • 2) By Application: Orthopedics; Arthritis; Chronic Tendinitis; Bone Repair & Regeneration; Dermatology; Androgenic Alopecia; Plastic Surgery; Dental; Cardiac Muscle Injury; Other Applications
  • 3) By End-Users: Hospitals & Clinics; Laboratories: Research Institutes
  • Subsegments:
  • 1) By Pure PRP: High Concentration PRP; Low Concentration PRP
  • 2) By Leukocyte-Rich PRP: PRP With White Blood Cells; PRP With Growth Factors
  • 3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF; Membrane PRF
  • 4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots; L-PRF Membranes
  • Companies Mentioned: Takeda Pharmaceutical Company Limited; Bio Products Laboratory Ltd.; Arthrex Inc.; Biotest AG; China Biologic Products Holdings Inc.; DePuy Synthes Companies; CSL Limited; Grifols S.A.; Octapharma AG; Terumo BCT Inc.; Pfizer Inc.; Kedrion Biopharma; ADMA Biologics Inc.; SK Plasma Co. Ltd.; Kamada Ltd.; Fusion HealthCare; LFB Plasma; Baxter International Inc.; Bayer AG; GC Biopharma Corp; Hualan Biological Engineering Inc.; Japan Blood Products Organization; PlasmaCare Inc.; ProMetic Life Sciences Inc.; Sanquin; Shanghai RAAS Blood Products Co. Ltd.; Canadian Plasma Resources; B Positive Plasma; Proesis Biologics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Plasma Therapy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Plasma Therapy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Plasma Therapy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Plasma Therapy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Growing Adoption Of Platelet-Rich Plasma (Prp) And Platelet-Rich Fibrin (Prf) Therapies
    • 4.2.2 Expansion Of Regenerative Medicine And Orthopedic Applications
    • 4.2.3 Increasing Use In Dermatology, Hair Restoration, And Plastic Surgery
    • 4.2.4 Rising Demand For Injectable And Membrane-Based Fibrin Products
    • 4.2.5 Integration Of Research And Clinical Trials For Enhanced Therapeutic Outcomes

5. Plasma Therapy Market Analysis Of End Use Industries

  • 5.1 Hospitals & Clinics
  • 5.2 Laboratories
  • 5.3 Research Institutes
  • 5.4 Dermatology Clinics
  • 5.5 Orthopedic & Sports Medicine Centers

6. Plasma Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Plasma Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Plasma Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Plasma Therapy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Plasma Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Plasma Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Plasma Therapy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Plasma Therapy Market Segmentation

  • 9.1. Global Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
  • 9.2. Global Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
  • 9.3. Global Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals & Clinics, Laboratories, Research Institutes
  • 9.4. Global Plasma Therapy Market, Sub-Segmentation Of Pure PRP, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High Concentration PRP, Low Concentration PRP
  • 9.5. Global Plasma Therapy Market, Sub-Segmentation Of Leukocyte-Rich PRP, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PRP With White Blood Cells, PRP With Growth Factors
  • 9.6. Global Plasma Therapy Market, Sub-Segmentation Of Pure Platelet-rich Fibrin (PRF), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Injectable PRF, Membrane PRF
  • 9.7. Global Plasma Therapy Market, Sub-Segmentation Of Leukocyte-rich Fibrin (L-PRF), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • L-PRF Clots, L-PRF Membranes

10. Plasma Therapy Market Regional And Country Analysis

  • 10.1. Global Plasma Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Plasma Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Plasma Therapy Market

  • 11.1. Asia-Pacific Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Plasma Therapy Market

  • 12.1. China Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Plasma Therapy Market

  • 13.1. India Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Plasma Therapy Market

  • 14.1. Japan Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Plasma Therapy Market

  • 15.1. Australia Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Plasma Therapy Market

  • 16.1. Indonesia Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Plasma Therapy Market

  • 17.1. South Korea Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Plasma Therapy Market

  • 18.1. Taiwan Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Plasma Therapy Market

  • 19.1. South East Asia Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Plasma Therapy Market

  • 20.1. Western Europe Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Plasma Therapy Market

  • 21.1. UK Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Plasma Therapy Market

  • 22.1. Germany Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Plasma Therapy Market

  • 23.1. France Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Plasma Therapy Market

  • 24.1. Italy Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Plasma Therapy Market

  • 25.1. Spain Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Plasma Therapy Market

  • 26.1. Eastern Europe Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Plasma Therapy Market

  • 27.1. Russia Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Plasma Therapy Market

  • 28.1. North America Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Plasma Therapy Market

  • 29.1. USA Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Plasma Therapy Market

  • 30.1. Canada Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Plasma Therapy Market

  • 31.1. South America Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Plasma Therapy Market

  • 32.1. Brazil Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Plasma Therapy Market

  • 33.1. Middle East Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Plasma Therapy Market

  • 34.1. Africa Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Plasma Therapy Market Regulatory and Investment Landscape

36. Plasma Therapy Market Competitive Landscape And Company Profiles

  • 36.1. Plasma Therapy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Plasma Therapy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Plasma Therapy Market Company Profiles
    • 36.3.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Bio Products Laboratory Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Plasma Therapy Market Other Major And Innovative Companies

  • DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp

38. Global Plasma Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Plasma Therapy Market

40. Plasma Therapy Market High Potential Countries, Segments and Strategies

  • 40.1 Plasma Therapy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Plasma Therapy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Plasma Therapy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer